{"id":14000,"date":"2024-01-18T20:21:23","date_gmt":"2024-01-18T20:21:23","guid":{"rendered":"https:\/\/www.gecp.pt\/?p=14000"},"modified":"2024-01-18T20:21:23","modified_gmt":"2024-01-18T20:21:23","slug":"novidades-no-tratamento-de-doentes-sem-alteracoes-geneticas-acionaveis_","status":"publish","type":"post","link":"https:\/\/www.gecp.pt\/en\/novidades-no-tratamento-de-doentes-sem-alteracoes-geneticas-acionaveis_\/","title":{"rendered":"News in the treatment of patients with no vested genetic changes"},"content":{"rendered":"<p>The last round table of the Autumn Meeting, entitled &#8220;News in NSCLC with Actionable Genetic Changes&#8221;, was moderated by several experts, including Dr. Marta Soares.<\/p>\n<p>By way of summary, the oncologist at IPO Porto states that in this session &#8220;new developments in the treatment of lung cancer with some types of rarer mutations for which there are still no approved therapies&#8221; were presented.<\/p>\n<p>Highlight is the &#8220;clinical trials already with some conclusions, namely on Ex\u00e3o20 and RET, with very promising results&#8221;, she comments. Although in other changes the results are not yet desirable, Dr. Marta Soares believes that &#8220;with the clinical trials that are taking place, in the near future, we will probably have news that will make us smile and think that the treatment of these patients will also be as effective as the others&#8221;, he concludes.<\/p>\n<p>See the full interview.<!--themify_builder_content-->\n<div id=\"themify_builder_content-14000\" data-postid=\"14000\" class=\"themify_builder_content themify_builder_content-14000 themify_builder tf_clear\">\n                    <div  data-lazy=\"1\" class=\"module_row themify_builder_row tb_vdgd345 tb_first tf_w\">\n                        <div class=\"row_inner col_align_top tb_col_count_1 tf_box tf_rel\">\n                        <div  data-lazy=\"1\" class=\"module_column tb-column col-full tb_muav346 first\">\n                    <!-- module divider -->\n<div  class=\"module tf_mw module-divider tb_cv0a664 solid\" style=\"border-width: 1px;border-color: #ffffff;margin-top: 10px;margin-bottom: 10px;\" data-lazy=\"1\">\n    <\/div>\n<!-- \/module divider -->\n<!-- module video -->\n<div  class=\"module module-video tb_uxd6863 video-top\" data-lazy=\"1\">\n                    <div class=\"video-wrap-outer\">\n            <div class=\"video-wrap tf_rel tf_overflow\">\n                                    <noscript><iframe data-no-script src=\"https:\/\/www.youtube.com\/embed\/9MW9Ia2r2fk?pip=1&#038;playsinline=1\" allow=\"accelerometer;encrypted-media;gyroscope;picture-in-picture;fullscreen\" class=\"tf_abs tf_w tf_h\"><\/iframe><\/noscript>\n                                <\/div>\n            <!-- \/video-wrap -->\n        <\/div>\n        <!-- \/video-wrap-outer -->\n            <\/div>\n<!-- module divider -->\n<div  class=\"module tf_mw module-divider tb_t3i3218 solid\" style=\"border-width: 1px;border-color: #ffffff;margin-top: 10px;margin-bottom: 10px;\" data-lazy=\"1\">\n    <\/div>\n<!-- \/module divider -->\n        <\/div>\n                        <\/div>\n        <\/div>\n        <\/div>\n<!--\/themify_builder_content--><\/p><!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>The last round table of the Autumn Meeting, entitled &#8220;News in NSCLC with Actionable Genetic Changes&#8221;, was moderated by several experts, including Dr. Marta Soares. By way of summary, the oncologist at IPO Porto states that in this session &#8220;new&#8230;<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>","protected":false},"author":1,"featured_media":14005,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"ngg_post_thumbnail":0},"categories":[183,118,189,160],"tags":[],"_links":{"self":[{"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/posts\/14000"}],"collection":[{"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/comments?post=14000"}],"version-history":[{"count":8,"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/posts\/14000\/revisions"}],"predecessor-version":[{"id":14019,"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/posts\/14000\/revisions\/14019"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/media\/14005"}],"wp:attachment":[{"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/media?parent=14000"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/categories?post=14000"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/tags?post=14000"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}